α1-Microglobulin/albumin ratio may improve interpretation of albuminuria in statin-treated patients.
نویسندگان
چکیده
BACKGROUND Statins can cause tubular proteinuria by inhibiting tubular reabsorption of urinary proteins. To distinguish between microalbuminuria originating from glomerular leakage of albumin and tubular microalbuminuria due to statin therapy, the α1-microglobulin/albumin ratio is evaluated in patients taking statins and compared to untreated patients. METHODS Ten apparently healthy subjects were given 40 mg of simvastatin and tested for urinary α1-microglobulin, albumin, creatinine and cystatin C, up to 24 h after administration. Additionally, urine samples of 76 statin-treated and 456 untreated patients presenting with micro-albuminuria (albuminuria range between 20 and 200 mg/L) were tested for α1-microglobulin and albumin. α1-Microglobulin/albumin ratios were compared. Total cholesterol was measured in 50 patients on statin therapy. RESULTS In the 10 apparently healthy subjects, a significant temporary increase of α1-microglobulin, albumin and α1-microglobulin/albumin ratio was observed after statin intake. In the group of 532 patients showing micro-albuminuria, those treated with statins showed a significantly higher mean urinary α1-microglobulin/albumin ratio then untreated patients. Urinary albumin concentrations were significantly higher in patients taking simvastatin than in patients on rosuvastatin treatment and they were also higher in patients on statin therapy with a total serum cholesterol concentration below 3.88 mmol/L than in patients with a total serum cholesterol concentration above 5.17 mmol/L. CONCLUSIONS Tubular proteinuria, caused by the use of statins, can be distinguished from glomerular proteinuria by a higher urinary α1-microglobulin/albumin ratio.
منابع مشابه
Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes
PURPOSE Urinary angiotensinogen has been reported as a marker for the activation of intrarenal renin-angiotensin system (RAS) in various kidney diseases. To investigate the importance of urinary angiotensinogen in diabetic nephropathy, we compared the urinary levels of angiotensinogen, albumin, and α1-microglobulin. MATERIALS AND METHODS Japanese patients with type 2 diabetes at various stage...
متن کاملOxidized LDL is Correlated with Urine Albumin in Type 2 Diabetes Mellitus: A Case-Control Study
Objective: In patients with diabetes mellitus, increased rate of lipoprotein oxidation and oxidative stress have important role in diabetic angiopathy, including nephropathy. We designed a study for comparing the level of Ox-LDL in diabetic patients with Macro-albuminuria, Micro-albuminuria, versus Normo-albuminuric. Materials and Methods: One hundred and thirty five patients with type 2 dia...
متن کاملEffects of additive therapy with spironolactone on albuminuria in diabetes mellitus: A pilot randomized clinical trial
Background: Early diagnosis of albuminuria and the prevention of its progression to macroalbuminuria and diabetic nephropathy are crucial. Angiotensin converting enzyme inhibitors (ACEIs) and antagonists of angiotensin II receptors type I (ARBs) are currently used as first-line treatment for albuminuria in these patients. The present study was conducted to assess the efficacy of addition of spi...
متن کاملAnalysis of a urinary biomarker panel for incident kidney disease and clinical outcomes.
Whether novel biomarkers improve the assessment of incident kidney disease and related adverse outcomes remains to be tested in longitudinal observational studies. We tested 14 urinary biomarkers for association with incident kidney, cardiovascular, and mortality outcomes in 2948 Framingham Heart Study participants. Baseline examinations were performed between 1995 and 1998; mean follow-up was ...
متن کاملAn Investigation of the Relationship between Beta-2 Microglobulin (β2M) and Inflammatory Factors (Serum Levels of CRP and Albumin) and High Density Lipoproteins (HDL) in Hemodialysis Patients
Background and Objective: Beta-2 Microglobulin (β2M) is a middle molecular weight uremic toxin. Lack of β2M removal leads to β2M accumulation and amyloidosis in hemodialysis patients. The present research aims to determine the relationship between β2M and inflammatory factors, such as C-reactive protein (CRP), albumin, and high-density lipoprotein (HDL) in hemodialysis patie...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Clinical chemistry and laboratory medicine
دوره 51 7 شماره
صفحات -
تاریخ انتشار 2013